We are live on ! Find out more

Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TAK icon
1
Takeda Pharmaceutical
TAK
$69B
$69B $21.59 0.75%
TEVA icon
2
Teva Pharmaceutical Industries
TEVA
$50.3B
$50.3B $43.11 3.12%
HLN icon
3
Haleon
HLN
$40.4B
$40.4B $9.20 0.33%
ZTS icon
4
Zoetis
ZTS
$34B
$34B $83.59 0.27%
UTHR icon
5
United Therapeutics
UTHR
$24.9B
$24.9B $583.70 1.26%
VTRS icon
6
Viatris
VTRS
$23.7B
$23.7B $20.63 0.91%
NBIX icon
7
Neurocrine Biosciences
NBIX
$16.7B
$16.7B $165.23 1.3%
ELAN icon
8
Elanco Animal Health
ELAN
$13.2B
$13.2B $26.41 1.38%
RDY icon
9
Dr. Reddy's Laboratories
RDY
$12.3B
$12.3B $14.71 0.2%
ALKS icon
10
Alkermes
ALKS
$7.89B
$7.89B $46.93 0.21%
KNSA icon
11
Kiniksa Pharmaceuticals
KNSA
$7.46B
$7.46B $94.90 1.48%
AMRX icon
12
Amneal Pharmaceuticals
AMRX
$7.37B
$7.37B $21.16 1.03%
LNTH icon
13
Lantheus
LNTH
$6.65B
$6.65B $101.75 0.16%
SUPN icon
14
Supernus
SUPN
$5.98B
$5.98B $28.77 3.2%
LQDA icon
15
Liquidia
LQDA
$5.05B
$5.05B $56.09 2.3%
HIMS icon
16
Hims & Hers Health
HIMS
$4.41B
$4.41B $18.81 4.66%
AMLX icon
17
Amylyx Pharmaceuticals
AMLX
$3.64B
$3.64B $28.35 6.4%
BHC icon
18
Bausch Health
BHC
$3.17B
$3.17B $8.46 1.32%
XERS icon
19
Xeris Biopharma Holdings
XERS
$3.04B
$3.04B $16.64 0.12%
HCM icon
20
HUTCHMED
HCM
$2.56B
$2.56B $14.75 1.01%
RGC icon
21
Regencell Bioscience
RGC
$2.35B
$2.35B $4.74 4.05%
PRGO icon
22
Perrigo
PRGO
$2.25B
$2.25B $16.18 0.37%
PBH icon
23
Prestige Consumer Healthcare
PBH
$2.25B
$2.25B $47.38 2.58%
BCRX icon
24
BioCryst Pharmaceuticals
BCRX
$1.95B
$1.95B $7.56 0.66%
ETON icon
25
Eton Pharmaceutcials
ETON
$1.84B
$1.84B $63.73 0.31%

Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 79 Drug Manufacturers - Specialty & Generic industry stocks tracked by Wall St. Rank, worth a combined $371B.

The largest by market cap are Takeda Pharmaceutical (TAK) at $69B, Teva Pharmaceutical Industries (TEVA) at $50.3B and Haleon (HLN) at $40.4B.

Among institutional investors, Trulieve Cannabis (TRLV) drew the most net new fund positions in Q2 2026: 123 funds opened new positions, taking total fund holders up 121 (2,017%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.